SpectraCure AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Other Revenue	-	-	-	0.54	-
Revenue	-	-	-	0.54	-
Cost of Revenue	-12.44	-9.77	-9.54	-3.05	-1.39
Gross Profit	12.44	9.77	9.54	3.59	1.39
Selling, General & Admin	36.66	31.62	30.91	28.72	27.76
Other Operating Expenses	0.91	-1.39	-2.5	-2.32	-5.71
Operating Expenses	67.7	32.86	31.07	29.27	24.71
Operating Income	-55.26	-23.1	-21.53	-25.69	-23.33
Interest Expense	-1.25	-0.47	-0.52	-0.18	-0.25
Interest & Investment Income	0.23	1.21	1.95	0.54	0.22
Earnings From Equity Investments	-	-0.69	-0.54	-	-
Currency Exchange Gain (Loss)	0.23	0.04	0.06	-	-
Other Non Operating Income (Expenses)	-	0	-	-	-
EBT Excluding Unusual Items	-56.05	-23.01	-20.59	-25.33	-23.36
Gain (Loss) on Sale of Assets	-	-	0.12	0.02	0.01
Asset Writedown	-	-	-	-0.06	-
Pretax Income	-56.05	-23.01	-20.46	-25.38	-23.35
Income Tax Expense	0.03	-0.01	-0.02	-	-0.01
Net Income	-56.08	-23	-20.44	-25.38	-23.34
Net Income to Common	-56.08	-23	-20.44	-25.38	-23.34
Shares Outstanding (Basic)	283	97	97	97	97
Shares Outstanding (Diluted)	283	97	97	97	97
Shares Change (YoY)	191.63%	-	-	-	5.11%
EPS (Basic)	-0.20	-0.24	-0.21	-0.26	-0.24
EPS (Diluted)	-0.20	-0.24	-0.21	-0.26	-0.24
Free Cash Flow	-24.03	-21.25	-18.68	-23.52	-18.77
Free Cash Flow Per Share	-0.09	-0.22	-0.19	-0.24	-0.19
Gross Margin	-	-	-	665.12%	-
Operating Margin	-	-	-	-4766.05%	-
Profit Margin	-	-	-	-4708.53%	-
Free Cash Flow Margin	-	-	-	-4363.82%	-
EBITDA	-54.93	-22.68	-21.03	-25.18	-22.87
D&A For EBITDA	0.34	0.42	0.51	0.51	0.46
EBIT	-55.26	-23.1	-21.53	-25.69	-23.33
Revenue as Reported	0.87	1.53	2.84	2.94	5.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.